Fig. 4

Decreased lipid-induced oxidative stress as measured by F₂-isoprostances (F₂-IsoPs) in PBMC and plasma. Baseline-corrected changes in F₂-IsoPs in PBMC with 16 mg galantamine vs. placebo during 20% intralipid infusion (A). Scatterplot showing F₂-IsoPs individual values in PBMC after placebo and galantamine at 2-h during lipid infusion (B). Baseline-corrected changes in circulating F₂-IsoPs in plasma with galantamine vs. placebo during 20% intralipid infusion (C). Scatterplot showing Fs-Iso individual values in plasma after placebo and galantamine at 2-h during lipid infusion (D). Values shown as means ± SEM, *P ≤ 0.05 by paired, two-tailed Student t-test